Diversified Healthcare Trust (NASDAQ:DHC) Reaches New 12-Month High – Still a Buy?

Diversified Healthcare Trust (NASDAQ:DHC)’s stock price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $7.66 and last traded at $7.5850, with a volume of 1473286 shares changing hands. The stock had previously closed at $7.50.

Analysts Set New Price Targets

DHC has been the subject of a number of research analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research report on Wednesday, January 21st. Zacks Research upgraded Diversified Healthcare Trust from a “strong sell” rating to a “hold” rating in a research note on Friday, February 20th. Royal Bank Of Canada boosted their price objective on Diversified Healthcare Trust from $5.00 to $6.00 and gave the stock a “sector perform” rating in a research report on Monday, March 2nd. Finally, B. Riley Financial raised their target price on Diversified Healthcare Trust from $6.50 to $8.50 and gave the company a “buy” rating in a report on Tuesday, March 3rd. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Diversified Healthcare Trust has an average rating of “Hold” and a consensus target price of $7.25.

Diversified Healthcare Trust Trading Up 0.9%

The company has a quick ratio of 2.36, a current ratio of 2.36 and a debt-to-equity ratio of 1.44. The firm has a market capitalization of $1.83 billion, a price-to-earnings ratio of -6.35 and a beta of 2.39. The business has a 50-day moving average of $6.14 and a two-hundred day moving average of $5.04.

Diversified Healthcare Trust (NASDAQ:DHC) last announced its quarterly earnings data on Monday, February 23rd. The real estate investment trust reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.21). The firm had revenue of $379.57 million during the quarter, compared to the consensus estimate of $392.89 million. Diversified Healthcare Trust had a negative return on equity of 15.98% and a negative net margin of 18.59%.

Diversified Healthcare Trust Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 19th. Stockholders of record on Monday, January 26th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, January 26th. Diversified Healthcare Trust’s dividend payout ratio (DPR) is presently -3.36%.

Insiders Place Their Bets

In other Diversified Healthcare Trust news, CEO Christopher J. Bilotto purchased 20,000 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was purchased at an average price of $4.89 per share, with a total value of $97,800.00. Following the completion of the transaction, the chief executive officer directly owned 266,285 shares of the company’s stock, valued at approximately $1,302,133.65. This trade represents a 8.12% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.37% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Diversified Healthcare Trust

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of Diversified Healthcare Trust by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 19,768,282 shares of the real estate investment trust’s stock worth $95,876,000 after buying an additional 205,285 shares during the period. Geode Capital Management LLC grew its stake in Diversified Healthcare Trust by 0.8% during the second quarter. Geode Capital Management LLC now owns 5,847,246 shares of the real estate investment trust’s stock worth $20,936,000 after buying an additional 44,759 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Diversified Healthcare Trust by 13.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 5,108,830 shares of the real estate investment trust’s stock valued at $24,778,000 after acquiring an additional 619,750 shares during the last quarter. Carronade Capital Management LP boosted its holdings in shares of Diversified Healthcare Trust by 4.4% in the 4th quarter. Carronade Capital Management LP now owns 4,763,537 shares of the real estate investment trust’s stock worth $23,103,000 after acquiring an additional 201,789 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its holdings in Diversified Healthcare Trust by 158.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 3,862,334 shares of the real estate investment trust’s stock valued at $9,270,000 after purchasing an additional 2,370,459 shares in the last quarter. 75.98% of the stock is currently owned by institutional investors.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.